Results 201 to 210 of about 27,755 (279)

Holding vs Continuing GLP-1/GIP Agonists Before Upper Endoscopy: The OCULUS Randomized Clinical Trial.

JAMA Intern Med
Ahmad AI, Garg S, Jacobs J, Ansari Z, Al-Din TJ, Almomani A, Valencia S, Vargo J, Chatterjee A, Siddiki H, Hong L, Nicolas MA, Miller A, Shah T.   +13 more
europepmc   +1 more source

Epithelial TMPRSS2 impairs glucose homeostasis in obese mice by regulating ghrelin-GLP-1 receptor signaling pathway. [PDF]

JCI Insight
Kaur D, Chakrabarty S, Witzler C, Wang H, Wang M, Wolz R, Wilgenbus P, Posma JJ, Rachakonda S, Marini F, Zinina VV, Reyda S, Gogiraju R, Graf C, Samad F, Schäfer K, Reinhardt C, Soshnikova N, Ruf W, Madhusudhan T.   +19 more
europepmc   +1 more source

GLP-1, GIP, and Glucagon Excursions During a Mixed Meal Tolerance Test in Young and Lean South Asians Versus Europids. [PDF]

Diabetes Obes Metab
Hoekx CA, Brinkman LBD, van Eenige R, Kooijman S, Muskiet MHA, Jazet IM, Martinez-Tellez B, Rensen PCN, Boon MR.   +8 more
europepmc   +1 more source

GIP receptor agonism suppresses inflammation-induced aversion and food intake via distinct circuits. [PDF]

Cell Rep
Province HS, Hayes NW, Leong NA, Tang E, Lorch CM, Pekerman A, Xia JL, Beutler LR.   +7 more
europepmc   +1 more source

GIP Regimen [PDF]

, 2020
openaire   +1 more source

GIPR:GCGR co-agonism restores normal weight in obese rodents. [PDF]

Mol Metab
Perez-Tilve D, Zhang F, Zhang Y, Lohman K, Sorrell J, Vick A, Müller TD, Tschöp MH, DiMarchi RD.   +8 more
europepmc   +1 more source

Real-world 6-month persistence, adherence, and effectiveness of GLP-1 medications for overweight and obesity in a Medicaid population. [PDF]

J Manag Care Spec Pharm
Meyer KB, McVeigh M, Chiara AN, Boss KC, Pomfret TC, Semmel K, Bacon R, Nicolas D, Clements K, Alper CJ, Lenz K.   +10 more
europepmc   +1 more source

Merging T1D and T2D Management: Shared Strategies for Common Goals-Building on Early Lessons From GLP-1 Trials in T1D. [PDF]

Diabetes Care
Bergenstal RM, Willis HJ, Carlson AL.
europepmc   +1 more source

Modulation of the tumor microenvironment by incretins and glucagon: Metabolic and immune mechanisms (Review). [PDF]

Exp Ther Med
Hu M, Jiang CJ, Yi C.
europepmc   +1 more source

GIP is back

Cahiers de Nutrition et de Diététique
Bernard Portha, Junjun Liu
openaire   +1 more source